virology

1. Ebola Virus (EVD)

2.  Ebola is a virus that lives in bats and some other animals who live in Africa.
 People can get Ebola in West Africa by preparing these sick animals for food.
 People can spread the virus to other people when they are very sick.
 This is the main way that people are now getting Ebola in West Africa.

3.  An infectious
Generally fetal disease marked by
 fever
Severe internal bleeding
Spread throughout contacts with:
Body fluids by Filovirus (Ebola Virus)
HOST
Unknown

4.  The three most affected countries are
 Guinea
 Liberia
 Sierra Leone
 People living in West Africa have gotten sick and some have died.

5. COUNTRIES AFFECTED WITH EVD

6. Named because of Ebola River

7.  People get Ebola by touching
 Infected animals (blood or meat).
 Blood or body fluids (urine, saliva, sweat, feces, vomit, breast milk, and semen) of
a person who is sick with or has died from Ebola Virus Disease (EVD)
 Objects (such as needles and syringes) contaminated with body fluids from a
person sick with EVD or the body of a person who died from EVD
 Infected fruit bats or nonhuman primates (such as apes and monkeys)
 Semen from a man who recovered from EVD (through oral, vaginal, or anal sex).
The virus can remain in certain bodily fluids (including semen) of a patient who
has recovered from EVD, even if they no longer have symptoms of severe illness.

9. Types of Body Fluids That involves in transmission of Ebola Virus
 BODY FLUIDS
EBOLA
VIRUS
Blood
saliva
sweat

13.  Symptoms may appear anywhere from 2 to 21 days after contact with the virus, with an average
of 8 to 10 days.
 Many common illnesses can have these same symptoms, including influenza (flu) or malaria.
 They cannot give Ebola to someone else until they
are showing symptoms.
Symptoms include:
 Fever
 Headache
 Tiredness
 Weakness
 Diarrhea

14.  Vomiting
 Stomach pain
 Muscle pain
 Unexplained bleeding
or bruising
 Only 3 in 10 of the people who have gotten Ebola during this outbreak have gotten
better.
 The sooner someone gets treatment, the more likely they are to get better.

16.  Ebola vaccine candidates against Ebola have been developed in the decade prior to
2014, but none have yet been approved for clinical use in humans.
 In December 2016, a study found the VSV-EBOV vaccine to be 70–100% effective
against the Ebola virus, making it the first proven vaccine against the disease

17.  Diagnosis
 Diagnosing Ebola Virus Disease (EVD) shortly after infection can be difficult.
 Early symptoms of EVD such as fever, headache, and weakness are not specific to
Ebola virus infection and often are seen in patients with other more common
diseases, like malaria and typhoid fever.

19.  Treatment
 Symptoms of Ebola Virus Disease (EVD) are treated as they appear. When used
early, basic interventions can significantly improve the chances of survival.
 These include:
 Providing fluids and electrolytes (body salts) through infusion into the vein
(intravenously).
 Offering oxygen therapy to maintain oxygen status.
 Using medication to support blood pressure, reduce vomiting and diarrhea and to
manage fever and pain.
 Treating other infections, if they occur.

21.  In most cases, people who have completely recovered from EVD do not go through
a comeback of the illness.
 However, many survivors suffer from health issues after recovery from Ebola.
The most commonly reported complications are:
 Tiredness
 Headaches
 Muscle and joint pain
 Eye and vision problems (blurry vision, pain, redness, and light sensitivity)
 Weight gain
 Stomach pain or loss of appetite

22.  Other health problems can include
 Memory loss
 Neck swelling
 Dry mouth
 Tightness of the chest,
 Hair loss,
 Hearing problems (ringing in the
ears and hearing loss),
 Pain or tingling in the hands and
feet,
 Inflammation of the pericardium
(tissue around the heart),
 Inflammation of one or both
testicles,
 Changes in menstruation,
 Impotence, decreased or lost interest
in sex, difficulty falling or remaining
asleep, depression, anxiety, and post-
traumatic stress disorder (PTSD).
 The timing of onset, severity, and
duration of complications among
EVD survivors are variable.

24.  https://www.cdc.gov/vhf/ebola/index.html
 http://www.myk104.com/prevention-ebola/
 https://www.compoundchem.com/2014/11/18/eboladrugs/
 https://www.researchgate.net/figure/Current-diagnosis-of-Ebola-virus/